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Abstract 
Physiological barriers inside of tumor tissue often result in poor interstitial penetration and 
heterogeneous intratumoral distribution of nanoparticle-based drug delivery systems (DDS). Novel, 
matrix metalloproteinase (MMP)-sensitive peptide-crosslinked nanogels (pNGs) as multistage DDS are 
reported with a beneficial size reduction property to promote the process of deep tissue penetration. 
Methods: The presented pNGs are based on a dendritic polyglycerol (dPG) scaffold crosslinked by a 
modified MMP-sensitive fluorogenic peptide. The crosslinker integrates degradability in response to 
proteases present in the tumor microenvironment. Surfactant-free, inverse nanoprecipitation is 
employed to prepare the nanogels using strain-promoted click chemistry. The size and crosslinking 
density of the pNGs are controlled by the functionalization degree of dPG with cyclooctyne groups and 
by the peptide crosslinker fraction. The intrinsic reporter moiety of the crosslinker was used to study the 
influence of pNG compositions on the degradation profile. The therapeutic drug Doxorubicin was 
conjugated through a pH-sensitive linkage to dPG to form a multistage DDS. The penetration behavior of 
the pNGs was studied using agarose matrix and multicellular tumor spheroids (MCTS).  
Results: Nanogel sizes were controlled in the range of 150–650 nm with narrow size distributions and 
varying degrees of crosslinking. The pNGs showed stability in PBS and cell media but were readily 
degraded in the presence of MMP-7. The crosslinking density influenced the degradation kinetic mediated 
by MMP-7 or cells. Stable conjugation of DOX at physiological pH and controlled drug release at acidic 
pH were observed. The digestions of nanogels lead to a size reduction to polymer-drug fragments which 
efficiently penetrated into agarose gels. Moreover, the degradable multistage pNGs demonstrated deeper 
penetration into MCTS as compared to their non-degradable counterparts. Thus, degradable pNGs were 
able to deliver their cargo and efficiently reduce the cell viability in MCTS. 
Conclusion: The triggered size reduction of the pNGs by enzymatic degradation can facilitate the 
infiltration of the nanocarrier into dense tissue, and thereby promote the delivery of its cargo. 
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Introduction 
Despite all the advances that have been achieved 
in the field of nanocarrier-driven drug delivery, many 
challenges remain [1-5]. One major obstacle is poor 
tumor penetration and heterogeneous distribution 
throughout the diseased tissue after extravasation of 
the nanoparticles from the vasculature [6, 7]. While 
the accumulation of nanocarrier-based drug delivery 
in tumor tissue mediated by the enhanced penetration 
and retention (EPR) effect has been well established 
for many setups in vivo, the corresponding 
improvement of the therapeutic efficiency has often 
been deficient [7-9]. This can be accounted, for 
instance, to the hampered penetration and uneven 









tumor which result from heterogeneous vasculature, 
high interstitial fluid pressure, and dense interstitial 
matrix [7, 10, 11]. Nanocarriers aiming for EPR-based 
delivery are typically in the size of 100-300 nm [6]. 
However, it was found that particles in this size range 
cannot easily penetrate into the interstitial space [12], 
leading to a heterogeneous distribution of particles 
within the malignant tissue. This impairs the 
treatment, and additionally the barely perfused center 
of the tumor harbors the most aggressive cells that 
have the potential to regenerate the tumor if not 
eliminated completely [13, 14]. Low exposure of drug 
in some regions of the tumor could even promote the 
development of drug resistance [15, 16]. Conventional 
small molecule therapeutic agents show fast diffusion 
in tumor stroma, they are however also rapidly 
cleared from body and tissues.  
One approach to improve intratumoral delivery 
is to carefully design multistage delivery systems that 
utilize specific stimuli in the tumor microenvironment 
such as pH or proteases to either achieve deeper 
tumor penetration, increased cellular uptake, and/or 
controlled drug release [17, 18]. The nanocarriers 
possess design features that allow the response to 
specific stimuli encountered in a consecutive manner 
[19]. Examples have been reported that respond to the 
slightly acidic tumor microenvironment (pH 6-7) with 
a size reduction by disintegration, sequential 
swelling/shrinking, or reorganization to enhance the 
diffusive properties of the particles [17, 20-22]. 
However, the acidic pH is typically located far from 
the blood vessels (pH gradient) which would hinder 
the response in the perivascular regions. As 
enzymatic reactions are highly specific and enzyme 
activity is strongly dependent on location, cell type, or 
the state of the targeted tissue, introduction of 
enzyme-responsive moieties into nanocarriers can aid 
to adapt the responsiveness of a drug delivery system 
(DDS) to the abundant proteases in the tumor 
microenvironment [23, 24]. Therefore, nanoparticles 
based on the natural polymers gelatin have been 
presented that encapsulate smaller entities like 
quantum dots or gold nanoparticles [25-27]. The idea 
of these carriers is that the gelatin shell can be 
degraded by extracellular proteases and thereby 
release the smaller entities, which can then more 
readily diffuse within the dense interstitial space. 
Gelatin is a substrate for matrix metalloproteinases 
(MMPs), a family of extracellular endopeptidases 
with the ability to degrade components of the 
extracellular matrix (ECM). Upregulated MMP 
expression has been reported for several malignant 
conditions where they are involved in tumor 
proliferation and invasion as well as metastasis 
[28-32]. The enzymes are located in the extracellular 
space and can be used for early detection and as 
biomarkers of disease progression and metastasis 
[33-35]. Alternative MMP-responsive moieties are 
peptides that can be applied as cleavable linkages to 
introduce site-specific biodegradation or drug release 
[36-39].  
Taking this into account, we designed 
multistage, MMP-sensitive, peptide-crosslinked 
nanogels (pNGs) that present suitable sizes to 
potentially accumulate in tumor tissue by the EPR 
effect and feature a protease-mediated size reduction 
property and acid-mediated drug release for 
enhanced tissue penetration. These degradable 
nanocarriers consist of a hydrophilic scaffold based on 
dendritic polyglycerol (dPG, Figure S1) that forms a 
three-dimensional network connected via 
MMP-specific peptide crosslinkers. The second 
building block is a rationally designed fluorogenic 
peptide crosslinker that comprises an MMP-specific 
amino acid sequence that is framed by a dye pair that 
exhibits fluorescence resonance energy transfer 
(FRET) and enables the monitoring of the peptide 
cleavage.[40] The incorporation of the fluorogenic 
peptide as crosslinker integrates degradability to the 
nanocarrier comprised of otherwise non-degradable 
polymers, and additionally, the cleavage of the 
crosslinks can be conveniently monitored by the 
intrinsic fluorescence reporter. The design was 
inspired by hydrogels prepared by Janda and 
co-workers that include MMP-sensitive crosslinkers 
in acrylamide gels to introduce degradability into 
synthetic hydrogels [41]. To transfer this concept to 
the nanoscale, we choose NGs as the nanometric 
equivalents of hydrogels that have emerged as 
platform for the development of novel 
nanocarrier-based strategies [42]. NGs are soft, 
hydrophilic hydrogel particles formed by physically 
or chemically crosslinked polymer chains that can 
incorporate stimuli-responsive moieties into their 
network to enable a triggered reaction ranging from 
morphological changes such as swelling or shrinkage 
to the disintegration of the polymer network [43].  
Classically, NGs are prone to efficiently 
encapsulate their cargo by physical interactions in the 
network structure. However, encapsulation can cause 
premature release of the payload by diffusion 
mediated leakage before reaching the site of action. 
Additionally, the release of the drug should be 
prevented after MMP-mediated degradation as this 
could cause fast clearance of the small molecular 
weight drugs. As an alternative, covalently bound 
therapeutics can prevent leakage, mediate enhanced 
solubility, and, when attached by dynamic covalent 
chemistry, can be released in a controlled manner [44]. 
To this end, we aimed to conjugate the 





chemotherapeutic drug doxorubicin (DOX) through a 
pH-sensitive linker to the dPG scaffold, thereby 
creating a multistage delivery system (pNG-DOX). In 
the first stage, pNGs can be degraded by MMPs which 
are present in the tumor microenvironment. After the 
resulting size reduction, the fragments constitute 
polymer-drug conjugates consisting of polyglycerol as 
polymeric carrier and DOX conjugated through an 
acid-cleavable linkage. These fragments should 
facilitate the penetration into deeper areas of tumor 
tissue where the cargo could be released at acidic pH 
as present in intracellular compartments (pH 4-5) 
such as endosomes and lysosomes (Figure 1) [45].  
We expect that the synthetic approach based on 
multifunctional building blocks and the directed 
incorporation of cleavable peptides allows precise 
control over the size and crosslinking density of the 
pNGs by varying the applied feed. Different 
crosslinking densities should result in different 
degradation profiles which can be tuned towards the 
specific application as multistage nanocarrier. In our 
system, the MMP-induced size reduction and 
degradation can be conveniently studied using the 
intrinsic fluorescence probe of the crosslinker. To 
prove the principle of the multistage drug delivery 
system, we investigate the diffusive transport of 
MMP-digested pNGs in a dense gel matrix mimicking 
the ECM. Furthermore, we expect an enhanced 
penetration of the carrier fragments and the drug into 
multicellular tumor spheroids (MCTS) which should 
result in an improved therapeutic activity of the drug.  
So far, the majority of the peptide-crosslinked 
nanocarriers only described the degradation to small 
fragments to release encapsulated cargo. To the best 
of our knowledge, the controlled introduction of 
peptide-based crosslinks into nanogels and the 
application as multistage delivery system has not 
been reported so far. 
Methods 
General Methods 
All chemicals were purchased from Acros 
Organics, Alfa Aesar, Roth, Merck, Sigma-Aldrich 
(now Merck), Deutero GmbH, and used as received. 
The design of the peptide crosslinker was adapted 
and modified from the work of Janda et al. [41] and 
the strategy of the crosslinker synthesis was 
developed in cooperation with Protein Research Inc. 
(UK). Structure and peptide sequence: Mca- 
Lys((OEG)8-N3)-Pro-Leu-Gly-Leu-Lys(Dnp)-Ala-Arg
-Lys((OEG)8-N3)-NH2 (Mca: 7-methoxycoumarinyl- 
4-acetic acid; Dnp: 2,4-dinitrophenyl; EG: ethylene 
glycol). Dendritic polyglycerol (dPG) was purchased 
from Nanopartica GmbH (Germany) with a weight 
average molecular weight (Mw) of 10 kDa (Dispersity 
Đ = 1.27). The cyclooctyne reagent (1R,8S,9s)- 
Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl 
carbonate was purchased from Synaffix (AE Oss, 
Netherlands). Water used for the synthesis was 
obtained from a Millipore water purification system. 
The pH-sensitive (6-maleimidocaproyl) hydrazone 
derivative of DOX (aldoxorubicin), was synthesized 
starting from 6-aminocaproic acid following a 
procedure from literature [46]. 1H NMR and ESI-MS 
spectra are shown in the SI. 
 
 
Figure 1. Schematic representation of the mechanism proposed for the multistage drug delivery by pNG-DOX. 





HeLa cells (DSMZ-No. ACC-57, Leibnitz 
Institute DSMZ- German Collection of 
Microorganisms and Cell Cultures) were routinely 
maintained in RPMI 1640 medium (Lonza) containing 
10% fetal bovine serum (FBS Superior, Merck), 1% 
Penicillin/Streptomycin (P/S, Thermo Fisher 
Scientific), and 1% MEM non-essential amino acids 
(Sigma-Aldrich) at 37 °C and 5% CO2. Human dermal 
fibroblasts from juvenile foreskin were isolated in 
accordance to local ethics and biosafety regulations 
(ethical approval EA1/345/14 by the Charité ethical 
committee) and were routinely cultured in Dulbecco's 
Modified Eagle Medium (DMEM) with 15% FBS and 
1% P/S at 37 °C and 5% CO2. 
Functionalization of dPG 
The hydroxyl groups of dPG were modified in 
three steps to obtain amine functionalities following 
published procedure (Scheme S1) [47]. Briefly, dried 
dPG (250 mg dPG, 0.27 mmol OH’s for 8%, 1.0 equiv.) 
was dissolved in N,N-dimethylformamide (DMF; 25 
mL) with triethyl amine (113 µL, 0.81 mmol, 3 equiv.) 
and cooled down to 0 °C. The hydroxy groups were 
activated by addition of methanesulfonyl chloride 
(23.0 µL, 0.30 mmol, 1.1 equiv.). The reaction was 
stirred overnight (18 h) and allowed to reach rt. The 
reaction mixture was diluted with MeOH (4:1 v/v) 
and dialyzed against MeOH for 2 d (Molecular weight 
cut-off (MWCO) 1000 Da). The degree of 
functionalization was determined by 1H NMR. 
Degrees of functionalization for dPG are given as a 
percentage of the total dPG hydroxyl groups (~ 135 
hydroxyl groups for 10 kDa dPG). For the next step, 
the polymer was dissolved in DMF and sodium azide 
(87.8 mg, 1.35 mmol, 5 equiv.) was added to induce a 
nucleophilic substitution of the mesyl groups. The 
reaction mixture was heated to 60 °C and stirred for 3 
d. After filtration, the filtrate was diluted with MeOH, 
dialyzed against MeOH for 2 d (1000 Da MWCO) to 
obtain dPG-azide. The appearance of a characteristic 
azide band was observed in the IR spectrum (2100 
cm-1) and the disappearance of the NMR signal for 
mesyl groups was monitored. To obtain dPG with 
amine functionalization, the azide groups were 
reduced by Staudinger reaction. Therefore, dPG-azide 
was dissolved in water/THF (1:1 v/v) and 
triphenylphosphine (213 mg, 0.81 mmol, 3 equiv.) was 
added before the solution was stirred for 3 d at 40 °C. 
Afterwards, TFA was evaporated and the remaining 
aqueous solution was filtered. The solution was 
dialyzed against MeOH for 3 d (MWCO 1000 Da). By 
this method dPG-amine with 4% and 8% degree of 
functionalization were obtained as determined by 1H 
NMR. dPG-amine war stored as solution in MeOH to 
avoid crosslinking and the concentration was 
determined gravimetrically after drying an aliquot of 
the solution. 
Functionalization of dPG with bicyclononyne 
groups (BCN) 
For the functionalization with cyclooctyne 
groups, dPG-amine (250 mg, 0.27 mmol amine groups 
for 8%, 1.0 equiv.) was dissolved in DMF (20 mL) 
before triethylamine (112.3 µL, 0.81 mmol, 3.0 equiv.) 
and (1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl 
N-succinimidyl carbonate (86.5 mg, 0.30 mmol, 1.1 
equiv.) were added (Scheme S2). The reaction was 
stirred for 3 h at rt. Then, the solution was diluted 
with MeOH (4:1 v/v) and dialyzed against MeOH for 
3 d (MWCO 1000 Da). Afterwards, the dialysis 
medium was changed to water for 2 d. dPG-BCN was 
stored in aqueous solution and the concentration was 
determined gravimetrically after an aliquot of the 
solution was lyophilized. The degree of 
functionalization was determined by 1H NMR 
yielding dPG-BCN with 3.9% and 7.8% conversion. 
1H-NMR (500 MHz, D2O, δ: 4.24-3.42 (m, 5H, dPG 
backbone), 2.31-2.14 (m, 6H, cyclooctyne), 1.60-1.28 
(m, 2H, cyclooctyne), 0.98-0.80 (m, 3H, cyclopropane) 
ppm. 
Preparation of pNGs 
For the synthesis of the pNGs, nanoprecipitation 
was employed using different degrees of 
BCN-functionalization and different feed ratios (see 
Table S1). As an example, dPG-BCN (4% 
functionalization, 4.1 mg, 2.2∙10-3 mmol BCN groups) 
and peptide crosslinker (2.0 mg, 1.6∙10-3 mmol azide 
groups, 70 mol%) were dissolved separately in water 
(1 mL) and cooled down in an ice bath. The cooled 
solutions were mixed and directly injected into 
NaCl-saturated acetone (20 mL) under vigorous 
stirring (900 rpm). After injection, the stirring was 
stopped, and the nanoprecipitation was left for 2 d at 
rt before the excess of BCN groups was quenched 
with either azidopropanol, indocarbocyanine azide 
(ICC-azide) or 11-Azido-3,6,9-trioxaundecan-1-amine 
to obtain pNG-OH, pNG-ICC or pNG-NH2, 
respectively. The dispersion was left for 1 d more 
before of water (1 mL) was added and acetone was 
evaporated. The aqueous dispersion was dialyzed 
against water for 3 d (MWCO 50 kDa). For the 
preparation of non-degradable controls, the same 
methodology was applied using the peptide 
crosslinker comprised of d-amino acids. pNGs were 
characterized by DLS and UV/Vis spectroscopy.  
Synthesis of multistage pNGs (pNG-DOX) 
pNGs (5 mg) quenched with 11-Azido-3,6,9- 
trioxaundecan-1-amine were reacted with 
2-iminothiolane hydrochloride (1.1 mg, 8.1∙10-3 mmol, 





3 equiv. of maximum amine groups) to convert the 
amine groups to thiols. After 20 min, the dispersion 
was filtered through a desalting column (PD10 
column; GE Healthcare) to separate remaining 
2-iminothiolane. The pNGs dispersion was 
concentrated by centrifugal filter devices (Vivaspin ®, 
MWCO 100 kDA) before aldoxorubicin (2.1 mg, 
2.7∙10-3 mmol, 1 equiv.), dissolved in DMF (0.1 mL), 
was added and left to stir for 4 h at rt. The pNGs were 
purified by size exclusion chromatography (SEC) 
using Sephadex G-25 fine matrix and subsequently 
dialyzed for 2 d in water (MWCO 50 kDa). Size 
distribution and zeta potential of pNGs were 
measured at 25 °C by DLS. The loading of labeled 
indocarbocyanine azide (ICC) or conjugated DOX was 
determined by UV-Vis spectroscopy. The NGs were 
stored as highly concentrated dispersions (5 mg mL-1) 
at 4 °C. The same methodology was applied for the 
preparation of non-degradable controls using the 
peptide crosslinker comprised of d-amino acids.  
Degradation study of pNG 
By dynamic light scattering (DLS) 
To follow the degradation of the pNGs by DLS, 
recombinant human MMP-7 (R&D Systems) were 
activated at 100 µg mL-1 with 1 mM 
p-aminophenylmercuric acetate (APMA) in a solution 
of 50 mM Tris base, 10 mM CaCl2, 150 mM NaCl, 
0.05% (w/v) Brij-35, and pH 7.5 (TCNB) for 1 h at 37 
°C. The enzyme solution was diluted to 0.4 µg mL-1. 50 
µL of NGs solution at 1 mg mL-1 were filled into low 
volume cuvettes (Sarstedt) and placed in the Zetasizer 
Nano-ZS 90 (Malvern). The reaction was initiated by 
addition of enzyme solution (50 µL at 0.4 µg mL-1). 
The particle size distributions were measured every 
30 min at 37°C over 16 h. 
By fluorescence 
The degradation was monitored by fluorescence 
intensity measurements over time following the 
fluorescence of 7-methoxycoumarin. pNG solutions of 
0.01–1.0 mg mL-1 were prepared in TCNB buffer and 
50 µL were loaded into a 96-well microplate. The 
reaction was started by adding 50 µL of the activated 
MMP-7 solution (0.02 µg per well). Plates included 
substrate and background controls containing pNGs 
with buffer and buffer only. As a positive control, a 
fluorogenic peptide (Mca-Pro-Leu-Gly-Leu-Dpa-Ala- 
Arg-NH2, R&D systems) was included at a 
concentration of 10 µM to confirm enzyme activity. 
The microplate was sealed with optically clear 
adhesive seal sheets (Absolute qPCR Seal, Thermo 
Scientific) and placed into a microplate reader 
(Infinite M200 Pro, Tecan) heated to 37 °C. The 
excitation and emission wavelengths were set to 320 
nm and 405 nm (top read), respectively, and 
fluorescence intensity was recorded every 5 min for 15 
h. The background signals of pNGs in assay buffer 
were subtracted and the fluorescence intensities, 
expressed as changes relative to the starting point, 
were plotted versus time.  
Release of DOX 
pNG-DOX dispersions in H2O were mixed with 
different buffers (1:1 v/v with acetate buffer (50 mM 
sodium acetate/acetic acid, 150 mM NaCl) at pH 5 or 
Tris buffer (50 mM Tris base, 10 mM CaCl2, 150 mM 
NaCl, 0.05% w/v Brij-35) at pH 7.5 with or without 
MMP-7) at 5 mg mL-1 and incubated at 37 °C. At 
specific time points (t = 0 min, 1 h, 2.5 h, 5 h, 8 h, 24 h) 
an aliquot of the solution was transferred to a SEC 
column containing Sephadex G-25 fine matrix to 
separate the free DOX from the NGs. The collected 
NG fraction was analyzed for remaining DOX by 
UV/Vis spectroscopy (absorption at 490 nm). 
Diffusion in agarose gels 
Agarose gels were prepared by heating a 
suspension of agarose in phosphate buffered saline 
(PBS; 0.5 w%) in a microwave oven at 500 W for 30 
seconds. The clear agarose solution was filled into 
rectangular capillaries of borosilicate glass 
(Hilgenberg, LxBxW: 80x4.2x1.25 mm, wall thickness 
120 µm). After gel formation at rt, NGs labeled with 
ICC (pNG-ICC, 0.1 mg) were incubated with either 
MMP-7 (final concentration 0.02 µg mL-1) in TCNB 
buffer or in buffer alone. After 16 h, 
ethylenediaminetetraacetic acid (EDTA) was added to 
inactivate the enzyme and 20 µL of the solution was 
filled into the capillaries on top of the agarose gel. In 
addition, free ICC in the same concentration was 
added to a capillary and then, the capillaries were 
kept at 37 °C in a humidified chamber for another 16 
h. The gels were imaged using a gel imaging system 
(GelDoc XRS+, Bio Rad) with green epi illumination 
(0.2 s exposure time) and 605/50 nm filter. The images 
were analyzed by ImageJ software.  
MCTS penetration 
After 9 d in culture (described in SI), spheroids 
were rinsed twice with PBS before fluorescently 
labeled pNGs-ICC, degradable and non-degradable 
control, or free ICC in RPMI medium without FBS and 
phenol red were added to the spheroids. The pNGs 
were added to a final concentration of 1.5 µM 
regarding the fluorescent dye. The spheroids were 
incubated for 2 or 16 h at 37 °C and 5% CO2. 
Afterwards, the medium was discarded, spheroids 
were washed three times with PBS, and fixed for 40 
min at rt in 10% neutral buffered formalin. Spheroids 
were washed again twice with PBS and cell nuclei 





were stained with DAPI solution (2.5 µg mL-1 in PBS, 
Sigma) for 1 h at rt. After washing with PBS, two 
complementary methods were applied to realize the 
visualization of the pNGs penetration into MCTS. For 
the first one, spheroids were transferred using 1 mL 
pipetting tips onto microscope slides, squeezed under 
microscopy cover slips and mounted with ProTaqs 
MountFluor (Quartett GmbH) mounting medium. For 
the second method, the fixed spheroids were stained 
with methylene blue (0.1% in PBS) for 10 min at rt. 
After washing with PBS, spheroids were transferred 
to Peel-A-Way® S-22 embedding molds (Merck) 
embedding molds and embedded in Surgipath FSC 22 
clear embedding compound (Leica) before the 
samples were frozen using liquid nitrogen. Then, the 
spheroids were cut into 16 µm-thick sections and 
mounted onto microscope slides. Images were 
acquired with a Leica SP8 CLSM using laser excitation 
at 488 nm (DOX) and 561 nm (ICC) with 20-fold and 
64-fold magnification. Image analysis was performed 
with LASX software and ImageJ. The circumference 
was determined in the brightfield images and then 
transferred to the intensity images. Subsequently, the 
measuring functions was used to determine the mean 
fluorescence intensity in the area of the MCTS. The 
same procedure was followed for analyzing the 
penetration of multistage pNGs (degradable and 
non-degradable and free DOX) into spheroids. Here, a 
concentration of 5µM regarding DOX was applied for 
all samples. 
Results and Discussion 
We propose the use of peptide crosslinked 
nanogels (pNGs) as a multistage drug delivery system 
(DDS) that features MMP-mediated size reduction 
properties in response to the tumor 
microenvironment followed by controlled drug 
release at intracellular, acidic pH conditions to aid 
enhancing tumor tissue penetration of conjugated 
DOX. To design a suitable pNG for this purpose, we 
considered the initial size of the pNG that potentially 
enables accumulation in tumor tissue by the EPR 
effect. This requires rather large particle sizes of 100–
300 nm [9]. In the tumor environment, extracellular 
MMPs would cleave the peptide linkers and thereby, 
cause a size reduction by degradation of the pNG to 
smaller fragments which should facilitate deeper 
tissue penetration. The size of the degradation 
products must be carefully controlled, since particles 
smaller than 30 nm may be cleared from tumor tissue 
while larger particles are retained and continue to 
accumulate [48]. It has been reported that micelles 
with sizes around 50 nm are able to penetrate tumor 
tissues and at the same time are more likely to be 
retained in the tumor tissue while smaller micelles of 
30 nm are susceptible to more rapid clearance [6, 8, 
12]. Therefore, we first systematically investigated the 
synthetic parameters and the influence of the different 
building blocks on the resulting properties of the 
pNGs with the goal to find a suitable candidate for the 
proposed multistage DDS. 
Formation and characterization of pNGs 
In the first step, we developed the methodology 
for the preparation of the MMP-sensitive NGs. The 
pNGs consist of dPG crosslinked by a fluorogenic 
peptide that can be cleaved by MMPs, as well as a 
chemotherapeutic drug attached via an acid labile 
linker to the polymer. The hyperbranched polymer 
dPG was chosen to form the hydrophilic scaffold of 
the pNGs and to allow facile functionalization [49]. 
Furthermore, dPG served as polymeric carrier of DOX 
after fragmentation. The hydroxy groups of dPG were 
converted to amine groups in a three-step approach 
following a known procedure [47]. Afterwards, the 
amines were reacted with (1R,8S,9s)- 
Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl 
carbonate to introduce cyclooctyne groups 
(dPG-BCN, Figure 2). 
To employ the fluorogenic peptide as 
crosslinker, it was modified with two terminal azide 
groups. These groups were attached through the 
γ-amino groups of lysine side chains including an 
8-unit oligoethylene glycol (OEG)-chain as spacer 
leading to the final structure: Mca-Lys((OEG)8- 
N3)-Pro-Leu-Gly-Leu-Lys(Dnp)-Ala-Arg-Lys((OEG)8
-N3)-NH2 (Figure 2). The additional OEG chains were 
introduced to increase water solubility and 
accessibility for the proteases. The functional groups 
allow strain-promoted alkyne-azide cycloaddition 
(SPAAC), a biorthogonal, metal-free click reaction 
that can be performed under mild conditions. 
Therefore, the reaction type allows the crosslinking of 
the building blocks without damaging the sensitive 
peptide and potentially enables the encapsulation of 
sensitive cargos [50]. 
NGs are usually prepared by templating the 
polymer in confined spaces and subsequent 
crosslinking inside these templates [51]. The most 
common methods are the mini- or microemlusion 
[52]. However, the high shear stress impairs the 
encapsulation of sensitive cargos and substantial 
amount of surfactant may alter surface properties 
when not carefully removed during purification. To 
bring the presented building blocks into nanosized 
assemblies, we employed the inverse 
nanoprecipitation technique [53-55]. This mild 
method avoids extended stirring/sonification (shear 
stress) and is surfactant-free. For the inverse 
nanoprecipitation, water was used as solvent and 





acetone was chosen as non-solvent. A constant 
polymer concentration of 3 mg/mL and a 
solvent/non-solvent ratio of 1:20 were selected as 
working parameters. These conditions were found to 
be optimal to obtain stable dispersions and were 
maintained for the synthetic screening. The 
cyclooctyne functionalities were used in excess and 
were quenched with azidopropanol, or alternatively, 
with an azide-functionalized indocarbocyanine dye 
(ICC) as florescent label. The crosslinking reaction 
was monitored by FT-IR spectroscopy which showed 
the disappearance of the azide signal at 2100 cm-1 
indicating the formation of triazoles by SPAAC 
(Figure 3a). 
We hypothesized that by varying the fraction of 
the peptide crosslinker in the feed and the 
crosslinking points on the dPG surface, different sizes 
and network densities would be obtained. The size is 
crucial for the fate of the pNGs in biological 
environment and the network has an influence on the 
degradation rate of the pNG which can be optimized 
for size reduction ability or alternatively to tune the 
release of an encapsulated cargo. Therefore, a rational 
screening included the variation of dPG-BCN 
functionalization degree and the fraction of peptide 
crosslinker in the feed to study their effect on the 
composition of the polymeric particles. Two degrees 
of BCN functionalization with 4% and 8% of 
converted hydroxy groups (~5 and 10 groups per 
dPG) were tested and the peptide crosslinker feed was 
varied from 10 to 70 w%. The hydrodynamic 
diameters and polydispersity indices (PDI) as 
determined by dynamic light scattering (DLS) showed 
narrow, monomodal distributions for the prepared 
pNGs (Table S1). To complement these results, we 
confirmed the formation of spherical particles by 
transmission electron microscopy (TEM) 
measurements. The sizes determined by statistical 
analysis of the TEM images revealed smaller 
diameters compared to the DLS measurements, which 
is due to drying and associated deswelling of the 
particles. For example, particle sizes of ~270 nm were 
determined for pNG4 by DLS, while TEM images 
revealed sizes of ~180 nm. Interestingly, pNG7 with a 
higher peptide feed displayed a size of 180 nm 
measured by DLS and only slightly smaller sizes of 
150 nm were determined by TEM indicating a denser 
network (Figure 3b).  
Overall, the screening of BCN functionalization 
and peptide feed confirmed that the sizes can be 
modulated in a broad range between 150 and 650 nm 
(Figure 3c). As expected, the nanogel size depends on 
the weight fraction of the peptide crosslinker. Here, 
smaller particle sizes were obtained with increasing 
peptide feed. The higher amount of crosslinker allows 
a stronger interconnection and additionally may 
provide stabilization during the nucleation and 
aggregation process yielding smaller particles. For 
higher BCN functionalization, we expected denser 
and smaller structures. Interestingly, an increase in 
sizes was observed when the number of BCN groups 
was doubled while maintaining the same peptide 
 
Figure 2. Schematic representation of the building blocks, synthesis, and structure of multistage pNG-Dox. 
 





fraction. Besides the solvent/non-solvent and 
polymer concentration, eventually, the character of 
the polymer is responsible for the stabilization of the 
aggregates to prevent coalescence or Ostwald 
ripening in the nanoprecipitation process [56]. 
Therefore, a higher functionalization of dPG seems to 
impair the potential of the polymer to stabilize smaller 
aggregates that has been observed for other 
dPG-based nanoparticles prepared by inverse 
nanoprecipitation [53, 55]. Our screening revealed 
that the stabilization by dPG in inverse 
nanoprecipitation is reduced by functionalization 
with hydrophobic BCN groups. Nevertheless, the 
tested feed composition allows an application- 
optimized size adaptation in a broad size range. 
Additionally, hydrodynamic diameters for pNGs in 
different media including Milli-Q water, PBS, cell 
culture medium (RPMI), and serum-containing 
solution (10% human serum in PBS) were determined. 
Here, small size changes were observed for nanogels 
in saline media (PBS, TCNB buffer and RPMI; table 
S2). The sizes measured in water exhibit sizes that are 
30% bigger than in saline-containing solutions 
indicating a higher swelling capability. It can be noted 
that no formation of larger aggregates was observed 
either in cell culture medium or in serum-containing 
solution. 
Size reduction and degradation kinetics of 
pNGs 
For the MMP-specific peptide sequence, it has 
been reported that MMP-7 is able to efficiently 
hydrolyze the crosslinker sequence which resulted in 
an increased fluorescence signal when incubated with 
the fluorogenic crosslinker (Figure S2a) [41, 57]. To 
confirm the degradability of the prepared nanogels, 
pNG6 (BCN 4%, 50 w%) was incubated in the 
presence and absence of the protease MMP-7. 
Subsequently, particle sizes were monitored by DLS 
over time. In the first 4 hours, we observed a slight 
increase in size indicating a swelling of the particles, 
which we think is due to partial cleavage of 
crosslinking points, and hence loosening of the 
network. After this time, apparent particle sizes were 
decreasing suggesting a disintegration of the pNG 
networks to smaller portions (Figure 4a). For pNG6, 
size reduction of approximately 75% compared to the 
initial size was observed after 16 h (Figure 4b). As 
controls for the specific degradation, pNGs were 
prepared by the same procedure but using a peptide 
crosslinker comprised of D-amino acids, which is not 
hydrolyzed by MMP-7 (Figure S2b). As seen in Figure 
4c, these non-degradable pNGs were stable upon 
incubation with the protease. These results confirm 
the MMP-mediated degradability and consequently a 
size reduction of the pNGs. The degradation was also 
confirmed by GPC measurements. Here, longer 
retention times for pNGs were observed after 
incubated with MMP-7 indicating fragmentation of 
the pNGs (Figure S3). It is well understood that MMPs 
play a pivotal role in the proliferation, invasion and 
metastasis of cancer since MMPs are one of the major 
class of enzymes to degrade the extracellular matrix, 
and thereby remodeling the tumor microenvironment 
[28]. MMP expression is upregulated at all stages of 
cancer; however, the levels of MMPs vary 
significantly between different cancer types and 
patients. Many factors influence the activity of the 
proteases such as local concentrations, presence of 
inhibitors, and level of infiltrating stromal cells, which 
are the major source of MMPs. Isaacson et al. have 
thoroughly reviewed the MMP upregulation, 
distribution as well as their role in cancer [58]. To 
illustrate the variation in MMP expression, the cancer 
tissue concentration of MMP-7 in colorectal cancer 
was determined to be 2.45 ng mg-1 whereas in 
pancreatic cancer was 143 ng mg-1. For all cancer 
types, an average value for MMP-7 of 20.9 ng mg-1 
tissue was given. To induce the degradation of the 
pNGs, we employed an activated MMP-7 
concentration of 200 ng ml-1 (≡ 0.2 ng mg-1; d = 1.0 kg 
m-3) in all assays. This corresponds to an MMP 
concentration which is one magnitude smaller 
compared to the conditions in colorectal cancer. 
Therefore, the applied MMP concentration is 
representative for conditions where MMP 
upregulation is moderate, but still higher than in 
healthy tissue and in the bloodstream. 
The fluorogenic peptide crosslinker was 
introduced to conveniently follow the degradation of 
pNGs by fluorescence measurement since upon 
cleavage of the peptide crosslinks, the fluorescence of 
the quenched 7-methoxycoumarin (Mca) dye is 
regained. A library consisting of four pNGs with 4% 
and 8% BCN functionalization as well as with low and 
high peptide crosslinker feed were incubated with 
MMP-7 and the fluorescence intensities of Mca (Em.: 
405 nm) were followed over time. The peptide feed 
and the BCN functionalization in the pNG formation 
should affect the interior composition. More BCN 
groups of the nanogels and higher peptide crosslinker 
feed should result in denser network structure which 
eventually should be reflected in slower degradation 
rates. The plot of the fluorescence intensities versus 
time showed indeed that higher BCN 
functionalization and constant peptide fraction 
resulted in slower degradation indicating a denser 
network structure (Figure 5).  






Figure 3. Characterization of pNGs. a) FT-IR spectra of dPG-BCN (red), peptide 
crosslinker (blue), and pNGs (green). b) Representative TEM images of pNGs with 4% 
BCN functionalization and 40 w% (pNG4) and 70 w% (pNG7) peptide crosslinker and 
the corresponding statistical analysis of the particle size distribution (red) and the DLS 
measurement (blue). c) Influence of the peptide crosslinker feed and dPG 
functionalization on pNGs sizes. 
 
Faster degradation was observed when the 
fraction of the peptide was reduced during the 
synthesis suggesting network structures, which are 
easier accessible for the proteases. Since the number of 
crosslinking points on the dPG was kept constant, 
higher peptide fractions can form denser networks 
which eventually lead to smaller particles as observed 
in the synthetic screening. The effect of peptide 
fraction on the degradation rate was more 
pronounced for pNGs prepared with 4% BCN 
functionalization. Here, the time constant, which 
describes how rapidly the degradation process occurs, 
was nearly increased threefold when the peptide 
fraction was doubled (1.3 h to 3.7 h), whereas for 8% 
functionalization, only a minor increase was observed 
(6.6 Table S3). It can be noted that the non-degradable 
pNGs did not show an increase of fluorescence signal 
when incubated with MMP-7 indicating that these 
pNGs are stable at proteolytic conditions (Figure S4). 
Since the pNGs are used as DDS, we were 
interested to see if cells were able to induce the 
degradation. Therefore, pNGs were incubated with 
HeLa cells and the fluorescence intensities of Mca 
were measured over time. Even though with slower 
rate, the fluorescence signal was increasing over time 





Figure 4. a) Hydrodynamic diameters of degradable or non-degradable pNGs after 
addition of MMP-7 (at t=0) over time. Error bars indicate SEM from three 
measurements. Normalized size distributions of b) degradable and c) non-degradable 
pNG before and after incubation with MMP-7 for 16 h. 
 
To exclude media effects and evaluate the 
stability of pNGs, nanogels were tested in different 
media including water, PBS, serum-containing cell 
culture medium, and serum. Degradable and 
non-degradable nanogels were incubated in the 
media and the sizes were measured by DLS shortly 
after mixing and after 24 h. In the DLS measurements, 
only small changes in sizes were observed indicating 
that the particles are stable in these media (Figure S6). 
In cell culture medium, as well as in serum, additional 
components are present which are detected by DLS 





and interfere with an accurate measurement. 
However, since the fluorogenic crosslinker is an 
indicator of cleavage, it can be used to assess the 
stability of the pNGs in these media. Therefore, the 
fluorescence signal of the Mca dye was also 
monitored over time for different media containing 
pNGs. Here, no increase in fluorescence intensity was 
observed either for PBS or for serum-containing 
medium indicating that the crosslinker is stable under 
these conditions (Figure S5). 
The incorporation of the fluorogenic peptide 
crosslinker allowed us to study the impact of different 
feed ratios and the dPG functionalization degree on 
the degradation rates which translates to different 
interior compositions of the pNGs. By varying the 
functionalization of dPG and the fraction of the 
peptide, the degradation rates showed time constants 
in the range of about 1 h to 6 h. Hence, we 
demonstrated that the formation of pNGs with 
increased feed of peptide crosslinker generated higher 
crosslinking densities which correspond to the slower 
cleavage rate. This should allow the tuning of the 
release kinetics of encapsulated cargo from rather fast 




Figure 5. Normalized fluorescence intensity at 405 nm (Ex: 320 nm) over time 
monitored for different pNGs after addition of MMP-7 (at t=0) at 37 °C. Lines 
represent exponential fits used to determine time constants for the degradation 
process. 
 
Conjugation of Dox to obtain multistage pNGs 
Considering the previous data, we chose pNG6 
as a suitable candidate for the formation of the 
multistage DDS because the nanogels presented sizes 
larger than 200 nm and constant degradation rates 
with desired MMP-mediated size shrinkage to 40–50 
nm fragments. Sizes above 200 nm are suitable for the 
accumulation process in tumor tissue following the 
EPR effect and additionally, should avoid 
internalization of the nanogels into normal and 
malignant cells [59]. Only after size shrinkage in the 
tumor microenvironment, the pNGs fragments can be 
readily taken up by the malignant cells where the 
chemotherapeutic drug can be released. To realize the 
covalent conjugation of therapeutic agent through a 
pH-sensitive linkage, we chose a known prodrug of 
the anticancer drug DOX, namely aldoxorubicin. This 
prodrug comprises a maleimide group readily 
reacting with free thiols. This thiol-binding DOX 
derivative was designed to hitchhike albumin as 
carrier in the blood stream by probing a specific 
cysteine of the serum protein [60-62].  
After the crosslinking process, the pNGs were 
easily modified by quenching the excess of BCN 
groups with an azide-functionalized cyanine dye 
(ICC-azide) to label the pNGs or with 
1-Azido-4,7,10-trioxa-13-tridecanamine (N3-TOTA) to 
introduce amine groups. The ICC label is used to 
follow the pNGs and the degradation fragments in the 
following diffusion and penetration experiments. 
After purification, the free amine groups were 
thiolated in situ using 2-iminothiolane. The formed 
thiols readily reacted in a Michael addition reaction 
with the maleimide groups of aldoxorubicin yielding 
multistage pNGs (Figure 2). The approach of in situ 
thiolation was chosen to avoid crosslinking of the 
reactive precursors. As before, non-degradable 
control pNGs were prepared using a peptide 
crosslinker synthesized with d-amino acids. The 
hydrodynamic diameters were barely affected by the 
modification of the pNGs with the drug, but the 
slightly positive surface charge was marginally 
increased by the attachment of aldoxorubicin HCl salt. 
The DOX contents of degradable and non-degradable 
pNGs were determined by UV/Vis spectroscopy with 
1.8 w% and 2.0 w%, respectively (Figure S7a+b). All 
synthesized pNGs had similar sizes and dye/drug 
loadings allowing to compare their potential to 
increase the penetration efficiency and their 
therapeutic activity (Table 1).  
The acid-mediated release of DOX from the 
pNGs was confirmed by incubation of the multistage 
pNGs at pH 7.4 and pH 5 as well as in the presence of 
MMP-7. Here, we found that the release of DOX is 
accelerated in acidic pH. In the first 24 h, ~50% of 
DOX was released at pH 5. In earlier studies, we 
reported a release of 60% at pH 5 for 
aldoxorubicin-derived polymer-drug conjugates [63, 
64]. The slightly lower release of the pNG-Dox system 
is probably caused by drug-carrier interaction within 
the nanogel network. Therefore, an increase in release 
is expected when the pNGs are first digested with 





MMP and subsequently, exposed to acidic pH values. 
Indeed, under these conditions the release was 
increased to ~60% (Figure S8). In the mentioned 
polymer-drug conjugates, release at pH 7.4 was 
marginal with less than 10% over several days. For the 
nanogels however a release of ~25% was observed at 
pH 7.4 indicating that DOX is not only covalently 
linked but also partially encapsulated, and therefore 
can leak out of the nanogel network by diffusion. 
Even intensive purification by dialysis and SEC 
column after the conjugation step did not change the 
release profile suggesting that a small fraction of 
encapsulated DOX always remained in the network.  
 











pNG cleavable 214 ± 4.9 0.117 +4 - 
pNG-DOX cleavable 218 ± 3.9 0.220 +9 1.8 
pNG-ICC cleavable 244 ± 4.8 0.105 +2 0.8 
pNG non-cleavable 193 ± 1.7 0.043 +5 - 
pNG-DOX non-cleavable 220 ± 3.4 0.100 +9 2.0 
pNG-ICC non-cleavable 212 ± 1.5 0.026 +3 0.8 
a) Mean hydrodynamic diameter and standard deviation from three measurements 
obtained by DLS in H2O at 25 °C. Intensity distribution is given; b) For ζ-potential 
measurements, electrophoretic mobility of the pNGs was analyzed following 
application of a 20 Vcm-1 electric field; c) Determined by UV/Vis spectroscopy using 
the extinction coefficient of the ICC dye and DOX, respectively. 
 
Diffusive transport in agarose matrix 
The potential of pNGs fragmentation by MMPs 
to enhance diffusive transport was studied by the 
penetration of digested and undigested pNGs in 
dense agarose matrix mimicking the dense ECM in 
tissue. For this, we first brought solutions of 
ICC-labeled pNGs and the non-degradable control 
pNGs, before and after incubation with MMP-7, in 
contact with the agarose gel and incubated for 16 h at 
37 °C. Before digestion, degradable and non- 
degradable pNGs presented negligible penetration 
into agarose gel. However, after incubation with 
MMP-7, the smaller fragments of the degradable 
nanogels were able to penetrate deep into the agarose 
matrix (Figure 6a) whereas the non-degradable 
control did not show any penetration. The intensity 
profiles of the fluorescence signal in the gel were 
plotted in Figure 6b. The signals for non-digested 
particles and for non-degradable control pNGs 
incubated with MMP-7 descends to 50% of the initial 
value after ~2.5 mm, whereas the intensity of digested 
pNGs was reduced to 50% of the initial value only 
after 8.9 mm indicating that the penetration is 
enhanced.  
Having confirmed an increased diffusion after 
pNG degradation using dye-labeled nanogels, we 
investigated the performance of the multistage DDS, 
pNG-DOX, in agarose gel diffusion. In this case, the 
intrinsic fluorescence of DOX allowed us to follow the 
infiltration. Before the incubation with MMP only 
marginal penetration of DOX was observed (50% after 
4.0 mm), whereas after incubation with MMP, the 
particles diffused into the gel matrix (50% after 6.8 
mm; Figure 6c+d).  
 
 
Figure 6. a) Diffusion of free ICC and ICC-labeled pNGs in agarose gel before and 
after incubation with MMP-7. b) Normalized intensity profiles of free ICC and 
ICC-labeled pNG in agarose gel. c) Diffusion of free DOX and pNG-DOX in agarose 
gel before and after incubation with MMP-7 and at acidic pH. d) Normalized intensity 
profiles of free DOX and pNG-DOX in agarose gel. 
 
To emulate the second step in the multistage 
delivery—the pH-dependent release of DOX from 
dPG by cleavage of the linking hydrazone bond—we 
further incubated the digested pNGs at acidic pH. 





Penetration of DOX into the agarose matrix was 
notably increased to 50% after 8.3 mm. This 
experiment confirmed an improved diffusion 
efficiency for degradable pNGs indicating that the 
fragmentation of the pNGs could improve the 
penetration into the interstitial matrix of tumor tissue. 
Penetration into multicellular tumor 
spheroids 
To confirm that the MMP-induced size reduction 
of pNGs can enable penetration into tumor tissue, we 
employed multicellular tumor spheroids to test the 
hypothesis in a tumor resembling 3D model. MCTS 
capture complex 3D tissue physiology such as 
presence of ECM as well as pH, oxygen, metabolic, 
and proliferative gradients and provide a useful 
technique to study anticancer strategies in vitro 
[65-69]. In particular; diffusion-based transport of 
nanoparticles in an environment that resembles the 
structural and microenvironmental conditions 
associated with solid tumors is of great interest [68, 
70]. For modeling the cellular diversity in tumor 
tissues, a variety of spheroid-based co-culture systems 
have been developed, e.g., with fibroblasts and 
endothelial cells [71]. Among the major cell types that 
are pivotal for conditioning the microenvironment are 
fibroblasts [72]. This infiltrating cell type is known to 
be coopted by tumor cells to promote invasion to 
other tissue, and thereby contributes to the formation 
of metastasis [73, 74]. In particular, fibroblasts 
contribute to tumor invasiveness by producing MMPs 
which regulate the remodeling of the surrounding 
ECM [73, 75]. Therefore, co-cultures of cancer cell 
lines and fibroblasts enable the formation of 3D 
spheroids models that resemble the tumor physiology 
or microenvironment and provide the proteases 
necessary to degrade the pNGs. 
To grow MCTS, HeLa cells and primary 
fibroblasts at different ratios and cell numbers were 
screened to reproducibly obtain spheroids with sizes 
of ~500 µm. For a mixture of HeLa and fibroblasts in 
ratio 2:1, spheroids were obtained after 4 days and 
further grew to dense circular structures with sizes of 
approximately 500 µm after 7–9 days (Figure S9).  
To investigate the diffusion properties of the 
DDS in MCTS, we first used the dye labeled pNGs. 
MCTS with sizes of around 500 µm were treated with 
ICC-labeled degradable (pNG-ICC) and 
non-degradable pNGs (non-degradable pNG-ICC). In 
the first set of experiments, spheroids were washed 
after incubation with the compounds for 16 h, 
transferred to a µ-slide, and the living MCTS were 
directly imaged using a CLSM. The z-stack function 
was used to optically section the spheroids in 40 µm 
steps. Here, we could indeed observe that the free dye 
and degradable pNGs yielded higher fluorescence 
intensity in deeper layers compared to the 
non-degradable control. However, when the images 
were compared with the brightfield image, it 
appeared that only the surface of the spheroids was 
imaged because the laser light is absorbed by the 
tumoroid tissue resulting in a limited penetration 
depth (Figure S10). To compensate the absorption of 
the laser light in large objects, the spheroids were 
mounted between microscope slide and cover glass 
and were thereby slightly squeezed (Figure 7b). These 
mounted MCTS allowed to image the central region of 
the spheroids by optical sectioning in the confocal 
microscope since the laser light does not need to 
penetrate into deeper layers. We found that the free 
dye used to label the pNGs had penetrated to the 
interior of the MCTS to a point where the signal 
abruptly decreased (Figure 7a), because the light 
absorption of the tissue becomes too large to obtain 
proper signals.  
 
 
Figure 7. a) Penetration of free ICC, degradable, or non-degradable pNGs labeled with ICC into MCTS. The black bars in the brightfield images represent 500 µm; CLSM images 
with 20-fold magnification. b) Schematic representation of the flattened spheroids and the optical sectioning. c) Mean fluorescence intensities of ICC in the area of the MCTS for 
increasing depth. 





Nevertheless, optical sections of spheroids 
treated with the degradable control displayed an 
efficient penetration into the spheroid. Compared to 
the free dye, the distribution of fluorescence signal is 
not as homogeneous for the degradable pNGs 
indicating that larger fragments may accumulate in 
more spacious regions of the spheroid. A distinct 
difference is apparent in comparison to the 
non-degradable control. Here, all sections displayed a 
low intensity and a marginal signal was observed in 
deeper layers confirming that the non-degradable 
pNGs are not able to diffuse into the MCTS. The 
graph in Figure 7c shows the mean fluorescence 
intensity (MFI) over the area of the spheroid section 
illustrating that free dye and the degradable nanogel 
display similar intensities over the total area of the 
section with slow decrease for deeper sections. 
To confirm the results obtained from optical 
sections, cryosections of the spheroids incubated with 
labeled pNG-ICC for 2 h and 16 h were prepared. 
Representative cryosections from the mid-region of 
spheroids were imaged by fluorescence microscopy. 
Free ICC and DAPI were found to be homogeneously 
distributed throughout the sections at both time 
points indicating an unhindered diffusion of the free 
dyes through the spheroid (Figure 8a). For the 
degradable pNGs and the non-degradable control, 
only minor intensities were observed at the margins 
of the spheroids after 2 h. For longer incubation time, 
we found minimally increased fluorescence intensity 
when treated with the non-degradable pNGs. At the 
periphery, intense signals were observed, however, 
the intensity was rapidly declining over the first 20 to 
30 µm towards the center of the section. When the 
degradable pNGs were incubated for 16 h with the 
MCTS, intense fluorescence was observed throughout 
the section area (Figure 8b + S11). The sections 
showed a gradient with higher fluorescence intensity 
at the periphery that decreased towards the core 
which is apparent from the images with higher 
magnification (Figure 8c). It is notable that the core 
still possessed distinct fluorescence intensity 
suggesting that the degradation products penetrated 
to the core of the spheroids. These observations 
support the results of the optical sections and confirm 
that the degradability of the pNGs are a favorable 
property for an efficient penetration of the 
tumor-resembling 3D model.  
Since we have shown before that the 
fragmentation of the pNGs is caused by proteases 
(Figure 4), we can assume that the increased 
distribution of the fluorescence signal associated with 
the nanogels and their fragments resulted from the 
degradation of the pNGs by expressed proteases. It 
has been reported that MMPs are indeed expressed in 
in vitro scenarios and in particular in co-cultures using 
primary cells [76, 77]. 
 
 
Figure 8. CLSM images of MCTS cryosections with 20-fold magnification. MCTS 
were incubated with free ICC, degradable, or non-degradable pNG-ICC for a) 2 h and 
b) 16 h, respectively. The black bars in the brightfield images represent 500 µm. Mean 
fluorescence intensities over the area of spheroid sections are shown in the SI (Figure 
S11). c) CLSM images of cryosections with 64-fold magnification. 
 
To demonstrate that the results obtained from 
the dye-labeled pNG can be transferred to the 
performance of the multistage pNG-Dox, spheroids 
were incubated with the multistage pNG-Dox, free 
DOX and the non-degradable control. After 





incubation, we could see that the free drug was 
distributed homogeneously throughout the spheroids 
with slightly decreasing fluorescence intensity for 
deeper regions. In comparison, the penetration for the 
degradable pNG-DOX was considerably higher than 
for the non-degradable control especially for deep 
sections of the tumor spheroids (Figure 9a). This 
indicates that pNGs are degraded and that the small 
fragments possessed an advantage in penetrating into 
deep regions of the 3D tumor model. Comparing to 
the penetration study using dPG-ICC, it can be noted 
that the DOX penetration for the non-degradable 
system was higher than for the non-degradable 
dPG-ICC (Figure 9b). This can be explained by either 
premature DOX release or diffusion of small fractions 
of encapsulated DOX.  
To complement this data, cryosections of MCTS 
incubated with pNG-DOX and controls were 
prepared for 2 h and 16 h (Figure S12). For the 
degradable dPG-Dox a time dependent increase in 
penetration depth of DOX fluorescence was observed, 
whereas for the non-degradable control no change 
was visible over time. The confocal images at higher 
magnification illustrate the enhanced penetration of 
DOX for the degradable pNGs (Figure 9c). These 
observations support the results of the optical sections 
and confirm that the size reduction property of the 
pNGs enhances the transport of the therapeutic agent 
into the tumor-resembling 3D model. 
Furthermore, the cryosections of the spheroids 
give information about the fate of the nanogels 
(Figure 8c and 9c). Here, it can be recognized that 
non-degradable nanogels are not localized in the 
cytosol but rather in the extracellular space. On the 
other side, the signal of samples with degradable 
nanogels can be found intracellularly. The 
observation supports the assumption that the intact 
nanogels with sizes larger than 200 nm are 
internalized less by cells [59]. Only after degradation, 
smaller fragments are readily internalized and able to 
release their therapeutic cargo in acidic 
compartments. This should result in a different 
therapeutic activity of DOX when transported by 
degradable or non-degradable nanogels which is 
discussed in the next part.  
Therapeutic activity of multistage pNG 
To confirm that DOX is still therapeutically 
active after degradation of the pNG and tissue 
penetration, we analyzed the activity of DOX on cell 
viability after incubation with pNGs in monolayer 
culture as well as in MCTS. For the monolayered 
culture, the viability was determined by the ability of 
the cells to metabolize MTT. The bare pNGs did not 
display any toxicity towards HeLa cells up to the 
highest concentration tested (0.25 mg/mL), whereas 
free DOX and the multistage pNG-DOX reduced the 
viability of HeLa cells significantly starting at 1 µM 




Figure 9. a) Penetration of pNG-DOX into MCTS: Comparison of free DOX, degradable multistage pNG-Dox, and the non-degradable control. The black bars in the brightfield 
images represent 500 µm; CLSM images with 20-fold magnification. b) Mean fluorescence intensity of DOX over the area of the MCTS for different penetration depth. c) CLSM 
images of cryosections with 64-fold magnification. 






Figure 10. Therapeutic activity of DOX in the multistage DDS. a) Cell viability after 
treatment with different concentration of pNG-DOX and controls in monolayer 
culture of HeLa cells. b) Cell viability after treatment with pNG-DOX and controls at 
10 µM DOX concentration in MCTS model after 48 h of treatment, respectively. 
Error bars indicate SEM from three independent measurements; untreated cells = 1.0 
response; stars indicate statistical significance between degradable and 
non-degradable pNGs determined by non-parametric t-test (* p < 0.1;** p < 0.05). 
 
Interestingly, minor toxicity towards HeLa cells 
was observed for the non-degradable control 
indicating that the degradability of the pNGs plays a 
crucial role for the therapeutic activity. Since the 
release of DOX for the pNGS was marginal at pH 7.4 
but increased under acidic conditions as found in 
intracellular compartments this result suggest that the 
internalization of non-degradable pNG is suppressed 
and that the small fragments of the degradable pNGs 
can be taken up more readily. This observation is 
supported by the magnified images of the spheroid 
cryosections. Here, the fluorescence signals associated 
with the digested pNGs (ICC, Figure 8c) and the drug 
(Figure 9c) are localized in intracellular compartments 
for the degradable pNGs whereas the signals for the 
non-degradable sample is mainly found in the 
extracellular space. This supports our assumptions 
that the intact nanogels are internalized less by the 
cells adding a targeting component to the multistage 
pNGs. 
We were interested to see if the difference 
between degradable and non-degradable pNGs in 2D 
cell culture can also be observed in the treatment of 
the 3D model with pNGs. After incubation of the 
spheroids with the pNGs, the viability of cells in 
spheroids was assessed by measuring intracellular 
adenosine triphosphate (ATP) content using the 
CellTiter-Glo® assay because only low signals were 
obtained with MTT. Here, the non-degradable control 
marginally inhibited the proliferation of the spheroids 
when treated with a DOX concentrations of 10 µM. In 
contrast, when treated with the degradable 
pNG-DOX, ATP concentrations were reduced to 22% 
relative to the untreated control (Figure 10b). The 
difference emphasizes that the degradation-induced 
penetration is crucial for the treatment of the tumor 
model to deliver the drug to the inner regions. 
Therefore, we suggest the two-stage strategy of the 
presented multistage pNGs as potential 
nanocarrier-based DDS for systemically applied drug 
delivery. After extravasation to the tumor tissue, the 
protease-mediated fragmentation could enhance the 
tumor penetration to promote uniform drug 
distribution.  
Conclusion 
In summary, we prepared a novel MMP- and 
pH-sensitive multistage delivery system in the form 
of pNGs. The incorporation of a smart fluorogenic 
peptide crosslinkers into a hydrophilic, dPG-based 
scaffold provided degradability into synthetic NGs 
comprised of otherwise non-degradable polymers. 
The size reduction of these particles can be triggered 
by an endogenous stimulus in the tumor 
microenvironment, and thereby promotes the 
penetration of polymer-drug conjugates into dense 
tissue. The pNGs were prepared by surfactant free 
inverse nanoprecipitation using strain-promoted click 
chemistry. The procedure yielded nanogels with 
spherical morphology and good to excellent size 
distribution. The variation of BCN functionalization 
on dPG and the fraction of the peptide crosslinker 
allowed control over the size and the degree of 
crosslinking. The size reduction property of the pNGs 
in the presence of MMP was demonstrated by time 
dependent size measurements showing the desired 
reduction from several 100 nm to sub-50 nm 
fragments. The MMP-mediated degradation was 
studied in detail by fluorescence measurements 
following the fluorescence recovery of the intrinsic 
reporter moiety of the crosslinker. Here, we found 
that the degradation rate depends on the feed ratio 
and BCN functionalization with slower rates for 
higher crosslinker feed. This feature could be used to 
tune the release rate of an encapsulated cargo. The 





pNGs were post-synthetically modified to covalently 
attach the chemotherapeutic drug DOX through an 
acid-sensitive hydrazone linkage. The size and surface 
charge were barely affected by the modification, and 
the release of DOX from the pNGs was enhanced at 
acidic conditions. The digested multistage pNGs 
showed enhanced diffusive transport through a dense 
gel matrix and we successfully demonstrated in 
tumor resembling MCTS models that the 
size-changing property of the pNGs promotes the 
infiltration of the functional chemotherapeutic drug 
into deeper tissue regions. Therefore, the multistage 
dPG constitutes a potential nanocarrier for systemic 
application to promote drug delivery in solid tumors. 
Given the difficulty to deliver chemotherapeutics 
homogeneously to the dense center of solid tumors, 
the developed multistage peptide-crosslinked 
nanogels present a promising design for efficient drug 
delivery to malignant tissue. Further, the facile and 
smart design provides unprecedented insights into 
the composition and degradation kinetics of the 
nanogels in situ due to the intrinsic reporter unit. The 
intrinsic reporter and the controlled release of a 
chemotherapeutic drug emphasize the theranostic 
character of the nanogel design. 
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